The London Clinic performs first-ever Speedboat Submucosal dissection for early colorectal cancerĀ 

27 April 2026

The London Clinic is the first private hospital in the UK to introduce and deliver this cutting-edge technique.

Headshot of the London Clinic consultant, Dr Roser Vega
Reviewed today by Dr Roser Vega Consultant Gastroenterologist
Image

The London Clinic is proud to announce a significant milestone in advanced endoscopic care: Dr Roser Vega has successfully performed the hospital’s first-ever Speedboat submucosal dissection (SSD), offering a highly innovative, organ-sparing treatment for patients with early colorectal cancer.

This achievement marks The London Clinic as the first private hospital in the UK to introduce and deliver this cutting-edge technique, reinforcing its commitment to pioneering minimally invasive treatments and improving patient outcomes.

Speedboat submucosal dissection (SSD) is a form of endoscopic submucosal dissection (ESD) performed using the SpeedboatĀ® device, an advanced surgical instrument that combines cutting, coagulation, and dissection capabilities in a single tool. The device uses innovative technology developed and manufactured by Creo Medical, enabling clinicians to perform highly precise and controlled removal of early-stage cancerous and pre-cancerous lesions from the gastrointestinal tract.

Unlike traditional surgical approaches, which may require partial removal of the colon, SSD offers a less invasive, organ-preserving alternative. Patients benefit from reduced recovery times, fewer complications, and the potential to avoid major surgery altogether.

Dr Roser Vega, Consultant Gastroenterologist at The London Clinic, commented:”We are delighted to bring this advanced technique to patients in the private sector. Speedboat submucosal dissection represents a major step forward in the treatment of early colorectal cancer, allowing us to remove lesions effectively while preserving organ function. This approach significantly improves patient experience and outcomes.”

The introduction of SSD at The London Clinic reflects the hospital’s ongoing investment in innovative technologies and specialist expertise. By offering this service, The London Clinic is expanding access to state-of-the-art, minimally invasive cancer treatments within the UK’s private healthcare sector.

This milestone further strengthens The London Clinic’s position as a leader in advanced endoscopy and patient-centred care.